Laboratory testing has proven the efficacy of the anti-microbial MGRSafeWall product protection system from MGR Foamtex against SARS-CoV-2, the virus that causes COVID-19.
MGRSafeWall uses the latest Biomaster silver-ion technology and was tested in Europe to ISO 18184 protocols using real aircraft cabin products to demonstrate efficacy of 96.8%.
The ability to complete commercial testing with SARS-CoV-2 is a very recent development as testing with the actual virus was previously only permitted in government facilities.
It is believed this is the first time real aircraft cabin materials have been tested with actual SARS-CoV-2, as until now, all testing used a substitute envelope virus as testing with the actual virus was previously only permitted in government facilities.
Biomaster testing has shown it is effective against a wide range of viral, bacterial and fungal threats.
MGRSafeWall can be used on both porous and non-porous cabin surfaces, either for new production or as an in-service treatment.
